Retatrutide is a once-weekly injectable medication being studied as a triple receptor agonist, meaning it targets GLP-1, GIP, and glucagon receptors
Its an extremely new term, and it really gained popularity in the past few years as people using these medications were reporting less intrusive and repetitive mental noise around food, says Matthew Breit, PhD, RDN, a post-doctoral researcher and registered dietitian at the University of Colorado Anschutz School of Medicine who specializes in nutrition and lifestyle weight loss intervention
Venanzi M, Savioli M, Cimino R, Gatto E, Palleschi A, Ripani G, Cicero D, Placidi E, Orvieto F, Bianchi E
A KLOW dosage chart is a reference table showing the concentration of each blend component at different BAC water reconstitution volumes
Zhou X, Liu F, Zhai S